Earnings

The Durham, North Carolina-based medical device company sells products for pain relief and musculoskeletal recovery, including hyaluronic acid injections, bone graft substitutes and ultrasound-based surgical tools. Pain treatments revenue rose 6% to $71 million. Surgical solutions grew 1% to $51 million, with ultrasonics posting …

Distributable cash flow was $93.0 million, or $0.437 per unit, versus $78.6 million a year earlier, an 18.4% rise (calculated). Adjusted EBITDA of $104.1 million compared with $88.1 million, up 18.1% (calculated). Black Stone is one of the largest owners and managers of oil …

Net income was $36.4 million, up from $21.8 million, andDiluted Earnings per Sharereached $1.04 against $0.58. For the first nine months of 2026,Net Incomewas $111.6 million, or $3.15 per diluted share, compared with $124.1 million, or $3.28, a year earlier.

Wholesale revenue rose 8% to $72.5 million on expanded packaged coffee distribution, entry into the dollar channel, grocery gains and pricing, partly offset by tradeInvestmentand weaker ready-to-drink sales. DTC revenue rose 8% to $30.2 million on third-party digital marketplaces. Outpost revenue fell 8% to …

Operating income increased $18.7 million to $132.1 million.Net Incomeattributable to the company was $101.7 million, compared with $82.1 million a year earlier, andDiluted Earnings per Sharewere $1.11 against $0.89.

Adjusted EPS moved the other way, falling to $1.61 from $1.70. The gap reflects certain items that reducedEarningsby $0.36 per share, mainly restructuring charges, against $0.91 per share a year earlier.Gross Profitslipped to $204 million from $220 million as cost of sales rose to …

The swing was driven by a $540 million non-cash loss from changes in theFair ValueofCommodityderivatives. Excluding that and other items, adjusted net income was $104 million, or $1.17 per diluted share, versus $123 million, or $1.46, a year ago.